Top

Indian Journal of Hematology and Blood Transfusion

28-09-2024 | Erythropoietin | Original Article

Etiology, Diagnosis, and Genetic Analysis of Polycythemia in Pediatric Population

Authors: Yaşar Cihad KILINÇ, Ahmet BOLAT, Orhan GÜRSEL, Cengiz ZEYBEK, Bülent ÜNAY

Published in: Indian Journal of Hematology and Blood Transfusion

Excerpt

What is already known on this topic: …

Lanzkowsky P, Lipton J, Fish JD (2016) Lanzkowsky’s manual of pediatric hematology and oncology. Elsevier

Ocas-Córdova S, Tapia V, Gonzales GF (2018) Hemoglobin concentration in children at different altitudes in Peru: proposal for [Hb] correction for altitude to diagnose anemia and polycythemia. High Alt Med Biol 19(4):398–403CrossRefPubMed

Kucine N (2020) Myeloproliferative neoplasms in children, adolescents, and young adults. Curr Hematol Malig Rep 15(2):141–148. https://doi.org/10.1007/s11899-020-00571-8CrossRefPubMedPubMedCentral

Cario H, McMullin MF, Bento C et al (2013) Erythrocytosis in children and adolescents-classification, characterization, and consensus recommendations for the diagnostic approach. Pediatr Blood Cancer 60(11):1734–1738. https://doi.org/10.1002/pbc.24625CrossRefPubMed

Cario H, McMullin MF, Pahl HL (2009) Clinical and hematological presentation of children and adolescents with polycythemia vera. Ann Hematol 88(8):713–719. https://doi.org/10.1007/s00277-009-0758-yCrossRefPubMedPubMedCentral

Tefferi A (2013) Diagnostic approach to the patient with erythrocytosis/polycythemia. UpToDate Waltham. http://www.uptodate.com/diagnostic approach to the patient with erythrocytosis/polycythemia. Accessed on Dec 10, 2020

Mithoowani S, Laureano M, Crowther MA, Hillis CM (2020) Investigation and management of erythrocytosis. CMAJ: Can Med Association J = J de l’Association medicale canadienne 192(32):E913–e8. https://doi.org/10.1503/cmaj.191587CrossRef

Tefferi A, Guglielmelli P, Larson DR et al (2014) Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis. Blood 124(16):2507–2513 quiz 615. https://doi.org/10.1182/blood-2014-05-579136CrossRefPubMedPubMedCentral

Passamonti F, Malabarba L, Orlandi E et al (2003) Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia. Haematologica 88(1):13–18PubMed

10.

Spivak JL, Silver RT (2008) The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal. Blood 112(2):231–239. https://doi.org/10.1182/blood-2007-12-128454CrossRefPubMed

11.

Behrman RE (2020) Nelson Textbook of Pediatrics / Richard E. Behrman [and Three Others] Editors. Twenty-one edition. (Behrman RE eE)

12.

Lichtman MA, Murphy MS, Adamson JW (1976) Detection of mutant hemoglobins with altered affinity for oxygen. A simplified technique. Ann Intern Med 84(5):517–520. https://doi.org/10.7326/0003-4819-84-5-517CrossRefPubMed

13.

Giona F, Teofili L, Moleti ML et al (2012) Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome. Blood 119(10):2219–2227. https://doi.org/10.1182/blood-2011-08-371328CrossRefPubMed

14.

Jaillard AS, Hommel M, Mazetti P (1995) Prevalence of stroke at high altitude (3380 m) in Cuzco, a town of Peru. A population-based study. Stroke 26(4):562–568. https://doi.org/10.1161/01.str.26.4.562CrossRefPubMed

15.

Gordeuk VR, Stockton DW, Prchal JT (2005) Congenital polycythemias/erythrocytoses. Haematologica 90(1):109–116PubMed

16.

Siegel FP, Petrides PE (2008) Congenital and acquired polycythemias. Deutsches Arzteblatt Int 105(4):62–68. https://doi.org/10.3238/arztebl.2008.0062CrossRef

17.

Ianotto JC, Curto-Garcia N, Lauermanova M, Radia D, Kiladjian JJ, Harrison CN (2019) Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review. Haematologica 104(8):1580–1588. https://doi.org/10.3324/haematol.2018.200832CrossRefPubMedPubMedCentral

18.

Lam JCM, Campbell S, Barnes C (2018) The boy with the ruddy face: an approach to polycythaemia presenting in childhood. J Paediatr Child Health 54(4):453–456. https://doi.org/10.1111/jpc.13820CrossRefPubMed

19.

Komninaka V, Flevari P, Ntelaki EE et al (2024) High-Oxygen-Affinity hemoglobins-Case Series and Review of the literature. J Clin Med 13(2). https://doi.org/10.3390/jcm13020458

20.

Guilpain P, Montani D, Damaj G et al (2008) Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases. Respir Int Rev Thorac Dis 76(3):295–302. https://doi.org/10.1159/000112822CrossRef

21.

Westhoff M, Litterst P, Kreppein U (2022) [Pulmonary Hypertension and Polycythemia vera]. Pneumologie 76(5):345–353CrossRefPubMed

22.

Passamonti F, Elena C, Schnittger S et al (2011) Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations. Blood 117(10):2813–2816. https://doi.org/10.1182/blood-2010-11-316810CrossRefPubMed

23.

Patnaik MM, Tefferi A (2009) The complete evaluation of erythrocytosis: congenital and acquired. Leukemia 23(5):834–844. https://doi.org/10.1038/leu.2009.54CrossRefPubMed

24.

Bento C, Percy MJ, Gardie B et al (2014) Genetic basis of congenital erythrocytosis: mutation update and online databases. Hum Mutat 35(1):15–26. https://doi.org/10.1002/humu.22448CrossRefPubMed

25.

McMullin MF, Harrison CN, Ali S et al (2019) A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline. Br J Haematol 184(2):176–191. https://doi.org/10.1111/bjh.15648CrossRefPubMed

Title: Etiology, Diagnosis, and Genetic Analysis of Polycythemia in Pediatric Population
Authors: Yaşar Cihad KILINÇ
Ahmet BOLAT
Orhan GÜRSEL
Cengiz ZEYBEK
Bülent ÜNAY
Publication date: 28-09-2024
Publisher: Springer India
Keywords: Erythropoietin
Erythropoietin
Epoetin alfa
Published in: Indian Journal of Hematology and Blood Transfusion
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-024-01887-8

ASH 2024 Annual Meeting Coverage

inMIND supports tafasitamab addition in follicular lymphoma

12-12-2024
Lymphoma
News

Combining tafasitamab with lenalidomide and rituximab significantly improves progression-free survival for patients with relapsed or refractory follicular lymphoma.

Featuring the official presentation video

12-12-2024
Mantle Cell Lymphoma
News

Add-on blinatumomab improves DFS in children with ALL

Promising response to loncastuximab tesirine in lymphoma

12-12-2024
Lymphoma
News

» View more highlights on the ASH 2024 hub page

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Targeted Therapy
On-demand webinar

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Keynote webinar | Spotlight on adolescent vaping

Springer Medicine

Etiology, Diagnosis, and Genetic Analysis of Polycythemia in Pediatric Population

Excerpt

ASH 2024 Annual Meeting Coverage

inMIND supports tafasitamab addition in follicular lymphoma

Transplantation can be omitted for certain MCL patients

Add-on blinatumomab improves DFS in children with ALL

Promising response to loncastuximab tesirine in lymphoma

» View more highlights on the ASH 2024 hub page

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Keynote webinar | Spotlight on adolescent vaping

Springer Medicine

Excerpt

Please log in to get access to this content

ASH 2024 Annual Meeting Coverage

inMIND supports tafasitamab addition in follicular lymphoma

Transplantation can be omitted for certain MCL patients

Add-on blinatumomab improves DFS in children with ALL

Promising response to loncastuximab tesirine in lymphoma

» View more highlights on the ASH 2024 hub page

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma